Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

10x Genomics, Inc., a life science technology company ... as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes ...

The Genomics Core houses a 10X Genomics Chromium iX which has the capacity to prepare ... most genomic data - including bulk and single cell RNAseq, ATAC-seq, Cut&Run, ChIP-seq, and Cut&Tag. We are ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Constantly escalating US-China tensions and sanctions on China’s semiconductor industry and import of advanced chips only compounded market participant ... In the long run, 10x Genomics targets that ...